Award for Prevatex’s scientific founder

Geelong, Australia May 8, 2019 – Prevatex Pty Ltd an emerging life sciences company focussed on developing and bringing to market next generation probiotics to restore and maintain a healthy maternal microbiome during pregnancy, is pleased to report [...]

2020-01-31T01:09:47+00:00May 8, 2019|

Prevatex awarded $85,000 grant

Geelong, Australia – Prevatex Pty Ltd an emerging life sciences company focussed on developing and bringing to market next generation probiotics to restore and maintain a healthy maternal microbiome during pregnancy, has been awarded a collaborative [...]

2020-01-17T01:17:59+00:00April 3, 2019|

Prevatex completes initial R&D goals

Geelong, Australia – Prevatex Pty Ltd an emerging life sciences company focussed on developing and bringing to market next generation probiotics to restore and maintain a healthy maternal microbiome during pregnancy, is pleased to announce that [...]

2020-01-17T01:17:24+00:00November 12, 2018|

Prevatex completes founder capital raise

Geelong, Australia – Prevatex Pty Ltd an emerging life sciences company focussed on developing and bringing to market next generation probiotics to restore and maintain a healthy maternal microbiome during pregnancy, is pleased to announce that [...]

2020-01-17T01:16:33+00:00December 15, 2017|

Prevatex licenses IP from the Barwon Infant Study

Geelong, Australia – Prevatex Pty Ltd an emerging life sciences company focussed on developing and bringing to market next generation probiotics to restore and maintain a healthy maternal microbiome during pregnancy, is pleased to announce [...]

2020-01-17T01:16:42+00:00October 1, 2017|